| DCB (N=17) |
NDB (N=15) |
P-value | |
|---|---|---|---|
| Age (years) | |||
| Mean (SD) | 59.5 (9.93) | 58.1 (10.6) | 0.769 |
| Median [Min, Max] | 58.0 [37.0, 73.0] | 57.0 [33.0, 71.0] | |
| Missing | 0 (0%) | 2 (13.3%) | |
| SEX | |||
| Female | 2 (11.8%) | 5 (33.3%) | 0.296 |
| Male | 15 (88.2%) | 10 (66.7%) | |
| HER2.IHC | |||
| 2+ | 6 (35.3%) | 3 (20.0%) | 0.571 |
| 3+ | 11 (64.7%) | 12 (80.0%) | |
| PFS_status | |||
| 0 | 14 (82.4%) | 0 (0%) | <0.001 |
| 1 | 3 (17.6%) | 15 (100%) | |
| OS_status | |||
| 0 | 16 (94.1%) | 8 (53.3%) | 0.024 |
| 1 | 1 (5.9%) | 7 (46.7%) | |
| FFPE.RNA.id | |||
| 0 | 2 (11.8%) | 5 (33.3%) | 0.296 |
| 1 | 15 (88.2%) | 10 (66.7%) | |
| PBMC.v1.id | |||
| 0 | 3 (17.6%) | 1 (6.7%) | 0.688 |
| 1 | 14 (82.4%) | 14 (93.3%) | |
| PBMC.v2.id | |||
| 0 | 7 (41.2%) | 3 (20.0%) | 0.364 |
| 1 | 10 (58.8%) | 12 (80.0%) | |
| PBMC.v7.id | |||
| 0 | 1 (5.9%) | 6 (40.0%) | 0.057 |
| 1 | 16 (94.1%) | 9 (60.0%) | |
| 总疗效评价 | |||
| PR | 17 (100%) | 14 (93.3%) | 0.949 |
| SD | 0 (0%) | 1 (6.7%) | |
| BOR | |||
| Mean (SD) | -0.635 (0.130) | -0.535 (0.158) | 0.368 |
| Median [Min, Max] | -0.611 [-0.868, -0.353] | -0.538 [-0.865, -0.163] |